NDC 43742-2174 – INFL Combination
Aconitum Napellus Whole 6 [hp_C]/mL; Human Adenovirus E Serotype 4 Strain Cl-68578 Antigen 9 [hp_C]/mL; Bryonia Alba Root 30 [hp_C]/mL; Eucalyptus Globulus… · Liquid · Oral
Product NDC43742-2174
Product details
- Brand name
- INFL Combination
- Generic name
- Aconitum Napellus, Adenoviren Nosode, Bryonia (Alba), Eucalyptus Globulus, Eupatorium Perfoliatum, Gelsemium Sempervirens, Influenzinum 2023-2024, Ipecacuanha, Kreosotum, Veratrum Viride
- Labeler
- Deseret Biologicals, Inc.
- Dosage form
- Liquid
- Route
- Oral
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketed since
- May 14, 2024
- Marketing end
- July 15, 2029
- Pharmacologic class
- Live Human Adenovirus Type 4 Vaccine
Active ingredients
- Aconitum Napellus Whole 6 [hp_C]/mL
- Human Adenovirus E Serotype 4 Strain Cl-68578 Antigen 9 [hp_C]/mL
- Bryonia Alba Root 30 [hp_C]/mL
- Eucalyptus Globulus Leaf 2 [hp_C]/mL
- Eupatorium Perfoliatum Flowering Top 30 [hp_C]/mL
- Gelsemium Sempervirens Root 30 [hp_C]/mL
- Influenza A Virus Whole 10 [hp_C]/mL
- Influenza A Virus A/darwin/6/2021 (h3n2) Whole 10 [hp_C]/mL
- Influenza B Virus B/austria/1359417/2021 Bvr-26 Whole 10 [hp_C]/mL
- Influenza B Virus B/phuket/3073/2013 Bvr-1b Whole 10 [hp_X]/mL
- Ipecac 3 [hp_C]/mL
- Wood Creosote 30 [hp_C]/mL
- Veratrum Viride Root 30 [hp_C]/mL
Uses, dosage, side effects and warnings for INFL Combination →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 43742-2174-1 | 30 mL in 1 BOTTLE, DROPPER (43742-2174-1) | May 14, 2024 |
Other INFL Combination products
- 43742-1953 Eucalyptus Globulus Leaf 2 [hp_C]/mL; Ipecac 3 [hp_C]/mL; Aconitum… · Liquid · Deseret Biologicals, Inc.
- 43742-2045 Eucalyptus Globulus Leaf 2 [hp_C]/mL; Ipecac 3 [hp_C]/mL; Aconitum… · Liquid · Deseret Biologicals, Inc.
- 43742-2079 Eucalyptus Globulus Leaf 2 [hp_C]/mL; Ipecac 3 [hp_C]/mL; Aconitum… · Liquid · Deseret Biologicals, Inc.
- 43742-2537 Aconitum Napellus Whole 6 [hp_C]/mL; Human Adenovirus E Serotype 4… · Liquid · Deseret Biologicals, Inc.